GeNeuro, a biopharmaceutical company developing treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe ...
COPENHAGEN, Denmark and NEW YORK, July 15, 2026 /PRNewswire/ -- HERVolution Therapeutics ApS, a biotechnology company pioneering human endogenous retrovirus (HERV)-targeting immunotherapies for ...
In a recent study posted to the medRxiv* pre-print server, a team of researchers studied how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection altered the expression of human ...
A retrovirus called HERV-H, which inserted itself into the human genome millions of years ago, may play an important role in pluripotent stem cells. The discovery, which may help explain how these ...
Discover the latest articles and news in related subjects. To evaluate more closely expression in epithelial cells of uninvolved and cancer tissues, we employed an LCM technique to isolate separately ...
Data published in the Lancet’s EBioMedicine shows that the pathogenic envelope protein of the human endogenous retrovirus W (HERV-W ENV) is found on lymphocytes of hospitalized patients with COVID-19, ...
In a recent study posted to the bioRxiv* preprint server, researchers developed a human endogenous retrovirus (HERV)-enveloped recombinant baculoviral deoxyribonucleic acid (DNA) vaccine to target the ...
Discover the latest articles and news in related subjects. In this study, we report different transcriptional expression levels of HERV-K10-like sequences – also called HML-2 (human MMTV-like, group 2 ...
Findings demonstrate HERV-K is required for senescence-associated inflammation in metabolically challenged cells and is reactivated in plasma of subjects living with obesity COPENHAGEN, Denmark and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results